Why does rabies still plague India in the 21st century? by Vanak, Abi Tamim
News & Views 
 
Welcome to the March 2017 issue of the Wellcome 
Trust/DBT India Alliance Newsletter. In this issue we bring 
to you updates on new research stories penned by our 
Fellows, funding opportunities, event updates and 
interesting interviews. This newsletter also features new 
India Alliance Fellows and the research they are pursuing. 
 
At the outset, we would like to congratulate our Fellow, Dr 
Amit Awasthi, (Translational Health Science and Technology 
Institute, Faridabad) who was awarded G P Talwar mid-
career Scientist Award 2016 by the Indian Immunology 
Society. Also, IA Fellow at IIT Kanpur, Dr Arun Shukla joins 
the editorial board of Wiley’s Journal of Cellular 
Biochemistry and was recently invited as a guest editor for 
Elsevier’s latest volume in the Methods in Enzymology 
series “Proteomics in Biology- Part A and B”.   
 
We are presently not accepting applications for any of our 
Fellowship schemes. Submitted applications are currently 
under review.  
 
In the Research Highlights section, IA Fellow, Dr Rupjyoti 
Talukdar (Asian Institute of Gastroenterology, Hyderabad) 
takes us through his recently published work elucidating 
the underlying molecular mechanisms in acute and chronic 
Pancreatitis pathogenesis and provides a curious 
connection between pancreatitis, diabetes and gut 
microbiome. Intermediate Fellow at Indian Institute of 
Science, Bangalore, Dr Purusharth Rajyaguru, writes about 
his latest research which elucidates the effect of RNA-
binding protein modification on gene regulation in a 
baker’s yeast model. Ecologist and IA Intermediate Fellow, 
Dr Abi T Vanak (Ashoka Trust for Research in Ecology and 
the Environment, Bangalore) makes a case for rabies 
control in India in an insightful piece set in the backdrop of 
his current research work. This newsletter also includes 
interviews of our Intermediate Fellow Dr Sreelaja Nair, Tata 
Institute of Fundamental Research, Mumbai and India 
Alliance Fellowship Committee member, Prof Mohan 
Balasubramanian, Warwick Medical School, UK.  
 
For those of you who missed our last issue,  we would like 
to highlight once again that the India Alliance “Event 
Support” has been replaced by our new funding scheme for 
interdisciplinary meetings-the “India I EMBO Symposia”, a 
joint collaboration between the India Alliance and 
European Molecular Biology Organization (EMBO) which 
aims to co-fund up to three meetings in a year in India that 
intend to address discovery and innovation through an 
interdisciplinary approach, with the speakers and 
participants discussing important global challenges in the 
context of the life sciences. Applications submitted for the 
first round are currently under review. The next call for 
applications will be made next month. More information on 
this funding opportunity is included in this issue and is 
also available on the India I EMBO Symposia website.  
 
The India Alliance continues to organise various Science 
Communication training activities. The India Alliance will 
be hosting a unique workshop “Visualising Science” in 
partnership with Nature India and National Institute of 
Immunology, which aims to introduce scientists to visual 
tools and methods that make science communication more 
effective and interesting. The issue includes short reports 
on our recently concluded 19th SciComm101 workshop in 
Manipal University and 15th biannual two –day SciComm 
Workshop in Hyderabad.  
 
On the Public Engagement front, we are excited to support 
the next public event around Mental Health “It’s Ok to Talk” 
organised by the PRIDE team at the Public Health 
Foundation of India, which coincides with WHO’s World 
Health Day next month. More details on these events are 
included in this issue.  This issue also includes highlights 
from a report prepared by the Wellcome Trust International 
Engagement based on a survey that gathered views of 
Public and Community engagement with research in India 
and Africa.  
 
As always,  we would like to extend our heartfelt gratitude 
to those who have contributed to this newsletter.  Special 
thanks to our Intermediate Fellow, Dr Abi Vanak for the 
cover image, where he is seen with an Indian Fox , tagged 
with a high-resolution GPS transmitter to track their 
movements, which helps Abi and his team to determine 
their possible interactions with dogs and transmission of 
infections such as rabies. 
 
As always, it’s a pleasure to receive your valuable 
comments and suggestions for the newsletter so please do 
keep them coming.  
 
Best wishes, 
Sarah Iqbal, PhD 
Public Engagement Officer 
Wellcome Trust/DBT India Alliance   
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Technology for Tuberculosis: 
Mobile phone-based directly observed 
treatment for supporting adherence to 
anti-tubercular treatment in India 
This study proposes an alternative to in-person DOT with mobile phone 
based video DOT along with counseling support. For this, patients will 
send in a video of themselves taking medications via their mobile 
phone and receive monthly adherence counseling (video DOT). 
The effectiveness of video DOT will be studied in a Randomized 
Controlled Trial (RCT) in treatment naïve tuberculosis patients. 
Consenting patients will be divided into two groups of 190 patients 
each, with an equal chance of being allocated to either group. One 
group will receive the video DOT intervention, while the other, the 
prevailing standard of care. Treatment completion and adherence along 
with the multidimensional impact of tuberculosis on the individual, i.e., 
costs of care, nutritive status, quality of life and emergence of multidrug 
resistance, will be studied over time. Perceptions regarding the 
intervention, studied through in-depth interviews in a subset of 
participants and analysed with a qualitative approach will assess if the 
intervention is patient centric and user friendly. 
Dr Rishikesh V. Behere 
Intermediate Fellow 2016 
(Clinical and Public Health 
Research Fellowship) 
 
KEM Hospital Research 
Center, Pune 
 
WEBSITE 
 
 
Investigating the impact of 
mother’s nutrition on the 
mental health of young adults 
of a prospective birth cohort 
Mother's nutrition during pregnancy can affect brain development of 
fetus. Vitamin B12 deficiency is common in Indian women, however 
they routinely receive only iron-folic acid supplements during 
pregnancy. At KEM hospital, Pune, group of 700 children are being 
regularly assessed since their birth in 1994 and their mothers Vitamin 
B12- folic acid levels were measured during pregnancy. In this study we 
will examine whether mother’s nutrition during pregnancy has long-
term effects on risk for mental disorders in offspring as well as brain 
size and its functions. This may provide scientific evidence for 
advocating micronutrient supplementation including iron-folic acid and 
vitamin B12 to all mothers during pregnancy. 
Dr Rishikesh Narayanan 
Senior Fellow 2016 
 
Indian Institute of Science, 
Bangalore 
 
WEBSITE 
 
 
Efficient information encoding 
in hippocampal neurons 
Neurons are thought to hold a central piece in the puzzle on how we 
learn and store memories. The amazing complexity of these cell-types 
— complete with their complex structure and the perpetually 
reorganizing innumerable types of protein molecules that define their 
function — however, has impeded progress towards a clear 
understanding of how they adapt to and store new information. In our 
current work, we ask if this complexity is the solution (rather than being 
the problem), which bestows upon neurons the ability to efficiently 
encode information through several disparate routes, while also not 
losing the semblance of their functional identity.  
Widespread prevalence, prolonged treatment and emergence of drug 
resistant strains resulting from suboptimal adherence to treatment, 
make tuberculosis a disease of public health importance both globally 
and in India. 
 
The current Indian guidelines for tuberculosis recommend an alternate 
day, directly observed treatment (DOT) regimen that will soon transition 
into a daily treatment regimen. Given this scenario, the logistics of daily 
treatment along with factors such as, forgetfulness, stigma, loss of 
wages and medication side effects, pose barriers to treatment 
adherence and completion. 
 
The ubiquity of mobile technology presents a unique opportunity to 
support tuberculosis treatment. However, evidence indicates the need 
for family, peer or counseling support along with such mobile phone 
interventions. 
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An investigation of the 
impact of chromosome 
organisation on global gene 
expression and evolution of 
bacteria 
Microbes rapidly adapt to their environment, be it the unique challenges 
posed by life in the human body, or in facing up to the plethora of toxins 
and nutrient shifts that they encounter everywhere. Over short timescales, 
they do so by changing the set of proteins and other molecules they 
produce, i.e. by changing gene expression states; and over longer 
timescales by making changes to their genetic material. At times, the two 
converge. We ask how large and reversible changes to the genetic 
material can result in gene expression alterations. Is the ability to do so 
hardwired in the genome? 
Dr Sarit S. Agasti 
Intermediate Fellow 2016 
 
Jawaharlal Nehru Centre for 
Advanced Scientific 
Research (JNCASR), 
Bangalore 
 
WEBSITE 
 
 
Super-resolution imaging to 
study cell structure changes 
in aging 
The cytoskeleton is an important cellular component, participating in 
various fundamental cellular functions. It acts as scaffold to maintain 
cell shape and internal organization. In addition, cytoskeleton plays 
crucial role in organelle transport, cell division, cell-cell 
communication, cell signaling, and ultimately defining cell fate. Due to 
their essential roles in various cellular processes, the cytoskeleton has 
been linked to the process of aging and progression of age-related 
diseases. However, majority of the current studies were performed to 
elucidate the role of a single or a very small group of cytoskeleton 
components during aging process. It should be noted that along with 
three major cytoskeleton building blocks, microtubule, actin filaments 
and intermediate filaments, there are a large number of auxiliary 
proteins that control their dynamics, assembly/disassembly, 
homotypical/heterotypical organization, and ability to cross-link with 
various organelles. Therefore, despite these progresses, a fundamental 
gap remains between our understanding of individual cytoskeleton 
component and the network level view of how different cytoskeleton 
components function collectively to maintain normal function and are 
altered during aging. My goal is to utilize an innovative DNA-based 
super-resolution imaging technique with high multiplexing power 
(>100X) for in situ cytoskeleton network mapping to elucidate the 
molecular and structural basis of cytoskeleton alteration during aging. 
Dr Regalla Kumaraswamy 
Intermediate Fellow 2016 
 
Center for Cellular and 
Molecular Biology, 
Hyderabad 
 
WEBSITE 
 
 
Structure, functions and 
recognition of long non-
coding (lnc) RNA 
All protein-coding genes in humans originate from about 2% of the 
genome and the remaining portion of the genome remains 
untranscribed or transcribed as non-coding RNAs. All available 
therapies and disease diagnostics today are based on this 2% of the 
coding-genome. Until recently, non-coding genome was believed to be 
‘junk’ DNA. However, recent studies have highlighted the importance of 
non-coding RNAs in various pathophysiological conditions. MicroRNAs 
(≈21nt-long) and long non-coding RNAs (lncRNAs; ≤200nt-long) are the 
two major classes of non-coding RNAs that regulate gene-expression. 
We and others have shown that microRNAs play a very important role 
in cardiovascular diseases. However information about the role of 
lncRNAs in this context is relatively scarce. General research focus in 
my lab at CCMB is to understand how lncRNAs regulate fate of the 
different major cellular subsets of the heart (cardiomyocytes, fibroblasts 
and endothelial cells). 
New INDIA ALLIANCE FELLOWS 
Dr Arunabha Chakrabarti 
Early Career Fellow 2016 
 
Tata Translational Cancer 
Research Centre (TTCRC), 
Tata Medical Center, 
Kolkata 
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Identifying predictive and 
prognostic biomarkers in 
Acute Lymphoblastic 
Leukemia (ALL) 
Alteration(s) in IKZF1 (a B-cell developmental gene, functions as 
transcription factor), alone or in combination with other gene 
mutations, induce downstream signaling pathways that promotes 
leukemic cell survival on chemotherapy and risk of relapse in ALL. 
Combination of sensitive genomic and proteomic analyses along with 
functional studies can identify molecular biomarker(s) and pathways 
that can be used to further risk-stratify ALL patients and identify 
alternate targets for therapy.  
 
The overall aim of the project is to identify predictive and prognostic 
biomarker of ALL for better risk stratification and alternative cost-
effective therapeutic approach. 
 
ALL therapy is risk-stratified using a complex algorithm. As a result of 
high-cost of treatment, outcomes in India and other developing 
countries have stagnated over the last 3 decades.  
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Early Career Fellow 2016 
 
National Center for 
Biological Sciences, 
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Modulation of physiological 
and oncogenic Ras protein 
signaling via plasma 
membrane clustering 
Activated KRas signaling is among the most common molecular drivers in 
human cancers, but therapeutic targeting of KRas remains a challenge. 
Emerging evidence suggests that the dynamics of KRas proteins in 
cellular membranes, in particular, their homo- and heterotypic 
interactions in nanoscale protein clusters in these membranes, drives 
KRas-mediated signaling. The central aim here is to elucidate the 
mechanisms that underlie KRas protein clustering in the plasma 
membrane, and its role in physiological and oncogenic signaling. 
 
The second objective is to investigate the role of cortical actin embedded 
beneath the cytoplasmic side of the plasma membrane in regulating the 
nanocluster architecture of Ras proteins. I hypothesize that the protein 
and lipid sorting by cortical cytoskeletal filaments create restrictive 
environment for the plasma membrane associated KRas protein diffusion 
and hence imparting a definite nanocluster architecture. This nanoscale 
organization of Ras proteins is essential for its signaling activity. This 
mechanistic control via cortical actin serves an internal feedback control 
mechanism to maintain high fidelity signaling at the plasma membrane 
especially in case of oncogenic KRas, which is uncoupled to receptor-
initiated signals. 
Dr Nisha N Kannan 
Early Career Fellow 2016 
 
Indian Institute of Science 
Education and Research 
(IISER) 
Thiruvananthapuram, 
Kerala 
 
WEBSITE 
 
 
Investigating circadian 
behavior in Drosophila 
Evidence from genetic and molecular approaches contributed 
significantly to our understanding on the molecular basis of circadian 
timing system. Molecular oscillation of circadian clock is based on clock 
genes such as period and timeless that drive the rhythmic expression 
of transcripts and product proteins. Regulation at various levels 
including transcriptional, post-transcriptional and post-translational 
mechanisms is important for the accurate functioning of the circadian 
clock.  Emerging evidence indicates an important role for post-
transcriptional regulation including from splicing, polyadenylation to 
non-coding functions by microRNAs. Among the post-transcriptional 
regulation, mRNA stability plays an important role in rhythmic 
expression and cycling of transcripts. Although microRNAs recently 
emerged as significant players in accurate timing of the circadian 
timing system, broad impact of microRNAs in circadian rhythm remains 
to be elucidated. To this end, my studies are focused towards 
elucidating micro RNA mediated post-transcriptional regulation of 
circadian rhythms. 
 
New INDIA ALLIANCE FELLOWS 
From intermediate to senior FELLOWSHIP   
Dr Thomas Pucadyil 
Senior Fellow 2016 
Indian Institute of Science Education and Research (IISER), Pune 
WEBSITE 
 
 Internalization of membrane receptors from the cell surface is 
vital to cellular physiology since it regulates nutrient uptake 
and display of adhesion molecules, ion-channels and antigen-
presenting receptors. Internalized receptors are sent to the 
lysosome for degradation or recycled back to the cell surface 
for additional rounds of endocytosis. The latter process is 
known as endocytic recycling and is managed by the 
endocytic-recycling compartment (ERC). Remarkably however, 
the mechanism by which vesicles are released from the ERC 
remains unclear. Every vesicle generated inside the cell is an 
outcome of a regulated process of membrane fission wherein 
a protein coat polymerizes around and severs a tubular 
membrane intermediate. Despite an appreciation of the 
ubiquitous nature of membrane fission reactions, identifying 
proteins that manage this process has been a tremendous 
challenge in contemporary cell biology. Our current research, 
generously funded by the Wellcome Trust/DBT India Alliance in 
the form of a Senior Fellowship, aims to address this question 
by taking a reconstitution approach to understand how 
proteins remodel and vesiculate membranes at the ERC. 
  
India Alliance Intermediate Fellows Dr Thomas Pucadyil, (2011) Dr Subba Reddy Maddika (2011) and Dr Amit Singh (2009) recently received our 
Senior Fellowship (Basic Biomedical Research Fellowship scheme). Here,  Dr Thomas Pucadyil and Dr Subba Reddy Maddika,  talk about their 
experience on the IA Fellowship  so far and their plans to build on their research in round  two of theFellowship.   
6. 
The national ICiCLe protocol, a TTCRC initiative, has created a 
modern-yet-simplified clinical management process for childhood 
ALL. This brings with it the opportunity to ask questions about the 
treatment response as-well-as develop new cost-effective tools for 
risk stratification and also investigate alternative therapeutic 
options in terms of repurposing drugs. This proteogenomic study 
both in cell lines as-well-as in patients with known IKZF1 status 
will have impact on alternative treatment strategy for ALL patients 
in India. 
india alliance fellowship : Round 2  
New INDIA ALLIANCE FELLOWS 
People who made it all possible. The supported membrane tubes 
(SMrT) assay system constitutes Srishti Dar's (left) and Sukrut 
Kamerkar's (right) thesis work. SMrT templates constitute our core-
assay system with which to understand the process of membrane 
fission. 
Dr Subba Reddy Maddika 
Senior Fellow 2016 
 
Centre for DNA 
Fingerprinting and 
Diagnostics (CDFD), 
Hyderabad 
 
WEBSITE 
 
 
Phosphatases are a group of ubiquitously expressing 
enzymes, which are responsible for the removal of a 
phosphate group of various proteins in a cell. 
Phosphatases play a crucial role in nearly every cellular 
process, including metabolism, gene transcription and 
translation, cell-cycle progression, protein stability, 
signal transduction, and apoptosis. While several kinases 
(their counterpart enzymes) have been found to be 
intricately involved in human malignancies, studies on 
the role of phosphatases are very limited.  
  
I started my independent scientific career at CDFD with 
the goal to establish a program on cellular 
phosphatases. We envisioned identifying and 
characterizing novel cellular functions and pathways 
controlled by phosphatases along with their role in 
human cancers. We initiated the program to address two 
important questions 
  
Can we identify novel cellular functions for 
phosphatases based on their interactors? 
Can we fill in any missing mechanistic links for the role 
of phosphatases that were already established? 
  
The Intermediate Fellowship awarded by the Wellcome 
Trust/DBT India Alliance at that stage of establishing my 
independent lab has been very critical in helping me 
address these questions. During my tenure as an 
intermediate Fellow, we proposed to utilize a proteomics 
based approach to establish the functional network of 
phosphatases in human cells. With the generous funding 
support from India Alliance, we established a detailed 
interaction network of 143 human phosphatases, which 
contains about 85% novel interactions. Using this 
approach, we readily established the concept of 
identifying novel functions for cellular phosphatases 
based on interacting partners. For example, we 
demonstrated that tumor suppressor phosphatase, PTEN, 
functions in endosome maturation via interacting with 
Rab7, a critical GTPase in this process. 
  
The IA Fellowship has provided me the freedom and 
flexibility to address all important research questions in 
establishing my independent program at CDFD. 
Importantly, the generous support from Wellcome 
Trust/DBT India Alliance made it possible for young 
scientist like me to try new and risky directions. The 
highly competitive Fellowship program coupled with 
generous funding support, timely review mechanism, 
and extremely interactive Annual Fellows Meeting, 
undoubtedly makes it the best funding program in the 
country today. The timely release of funds, prompt 
response from the IA office including the Grant Adviser 
and Finance Manager was fantastic and definitely 
helped us in carrying our experiments in an unfettered 
manner.  The Fellowship has truly helped us in asking 
bigger and bolder questions. I can strongly state that our 
work would not have reached the stage it is at right now 
without the support of the IA Intermediate Fellowship.  
  
Having taken the early steps with intermediate 
fellowship, we now proposed to identify novel cellular 
functions for different phosphatases and characterize 
their importance in various cellular pathways based on 
our phosphatase interactome. As we are at the critical 
juncture of taking forward our program on 
phosphatases, it is highly important to have an 
unfettered support. Thus, the Senior Fellowship awarded 
to me by the Wellcome Trust/DBT India Alliance will now 
make it possible for me to expand into new directions, 
provide high quality training for graduate students and 
importantly assist in addressing the basic questions in 
phosphatase biology. 
I have invested close to 10 years researching membrane fission both as a 
Postdoctoral Fellow at the Scripps Research Institute and now as an 
Associate Professor at IISER Pune. During this period, my lab has been 
instrumental in designing novel model membrane assay systems with 
which to interrogate the process of membrane fission. The generous 
funding support the lab has received from the Wellcome Trust/DBT India 
Alliance in the form of an Intermediate Fellowship has yielded a novel 
high throughput assay platform that can be utilized in understanding 
membrane fission from a systems biology perspective. The assay lends 
itself easily to assaying membrane fission activity in cell lysates and 
designing small molecule inhibitor screens for such activity. The success of 
this assay is realized in numerous requests for collaborations we have 
received since the paper describing our results was published. I am very 
grateful for the generous financial support already provided by the India 
Alliance and to fostering a platform where strong collaboration are forged; 
not just those based on science but also ones that organically manifest 
between compatible personalities.  
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INDIA ALLIANCE FELLOW IN SPOTLIGHT 
Dr Sreelaja Nair 
Intermediate Fellow, Tata Institute of Fundamental Research, Mumbai 
Please tell us what you are working on and what impact do you hope it 
will have. 
 
Each species has a defined amount of DNA, which is known as the 
chromosome number. For humans this number is 46 represented by 23 
pairs, one set of which comes from the father and one set from the 
mother. Several congenital diseases have abnormal chromosome 
numbers such as Down`s syndrome. A drastic change in chromosomal 
numbers is also a cause of spontaneous abortions and is a hallmark of 
cancer cells. In disease conditions such as myocardial infarction, the 
heart cells at the site of the blockage change their chromosome 
numbers. All of these are ploidy syndromes and we use zebrafish to study 
the importance of fidelity in chromosome number for development of an 
embryo.  
 
Zebrafish are native to India and are found extensively across rivers in 
the country. We find that when we change the chromosome numbers in 
zebrafish embryos, the embryo attempts to alter a machinery inside cells 
known as the mitotic spindle that allow the chromosomes to separate 
equally when a cell divides. What was unexpected is that embryos alter 
mitotic spindle parameters even at the one cell stage, very soon after 
fertilization. In some sense, altered chromosome numbers sets the stage 
completely wrong for normal development. We are trying to understand 
exactly how it goes wrong and why. We are also trying to model altered 
ploidy conditions seen in disease states such as myocardial infarcts in 
the zebrafish heart. Hopefully, the information will be helpful in 
understanding why cells allow ploidy changes to happen and once it 
happens why it is bad for normal development. 
 
What motivated you to become a scientist?  
 
On a practical level, we are part of the biological world around us and 
we must understand the biology of ourselves as a species and that of 
species around us to justify placing ourselves at the top of the 
evolutionary pyramid.  
 
If I have to articulate it on a more personal level, I think I was drawn in 
by the idea of solitude. I don’t mean solitude in terms of isolation and 
remoteness, which is bad for scientific and intellectual growth. I mean 
solitude as in private-ness. Ultimately a scientific endeavour is a long 
conversation in your mind and I find it quite apt that all scientists get a 
degree in philosophy.  
 
Is there a research area other than yours that interests you deeply? 
 
I love the phenomenon of a one-cell becoming a complete organism. I 
can watch movies of development over and over again and still watch it 
one more time with equal fascination. At first glance the transformation 
into an embryo or larvae seems magical. But this magic is governed by 
strict rules of evolution, which executes a precise molecular and cellular 
program at an equally precise time and space in the embryo. Discovering 
some of these rules is and will continue to be my fascination as long as I 
live. Zebrafish is an incidental choice as my current muse and in this 
organism understanding fundamental mechanisms of cell division 
currently occupies most of my awake time. However, recently we have 
accidentally gotten involved in attempting to understand the role of a 
transcription factor in development of the habenula. The habenula are 
thought to be the reward-punishment centers in the brain. This is 
something I have never worked on in my career, but I am excited about 
understanding how a vertebrate embryo sets this center up during 
development. So besides ploidy, I have been trying to devour everything I 
can get my hands on regarding the habenula!  
 
What must we do to encourage a stronger Postdoc culture in India? 
 
We will only be able to seed a postdoc culture in India when we are able 
to provide jobs for our in-house trained postdocs. They must be able to 
view the option of continuing in or coming back to India for a postdoc as 
a productive addition to their career trajectory, not as a compromise due 
to personal or other circumstances. At the same time a stint in the 
research environment of a foreign country is a necessary part of ones 
growth as a member of the global research community. India Alliance’s 
Early Career Fellowship provides for this opportunity, which is a step in 
the right direction. We need to erase the general impression that 
postdocs trained outside India are better than the ones trained-in-house. 
Currently, this impression has elements of truth in it and there are of 
course certain exceptions.  
 
In India the academic structure in a lab is very top and bottom heavy. At 
the top you have the principal investigator (PI) and at the bottom, the 
students. Postdocs would be a fantastic pool of skilled intellectually 
driven individuals to occupy the middle tier as research associates. We 
have no provisions for it in the current academic structure. As of now, 
unless a postdoc gets a job as a PI or joins a company, academia has very 
few positions that offer job security to the large masses of postdocs that 
are currently getting trained in India. 
 
How has Wellcome Trust/DBT India Alliance funding helped you and your 
research? 
 
The Intermediate Fellowship from Wellcome Trust/DBT India Alliance is 
absolutely great to have. The financial independence from institute 
funding during the very early stages of my career is liberating, a little 
shot in the arm, like a confidence booster! It truly allowed me to exercise 
some freedom in the kinds of people I was able to recruit for my lab and 
other expenses such as travel and some experiments that would 
otherwise not have gotten done.  
 
The peer-review feedback on my research proposal was very useful when 
I was starting out. Through the annual meetings and other forum where 
fellows run into each other, there is a sense of belonging to a lively 
young research community in India, which is very crucial for a growing 
science economy. 
 
What keeps you going everyday? 
 
I still get as excited as my students when they see a result for the first 
time and try to interpret it in context of what they are studying. The 
sharpness of that feeling never dulls. The only difference between my 
student`s reaction to a result and my reaction is that I am equally 
intrigued by negative results, while they get disappointed when they 
encounter one. Despite all the stressors associated with being a scientist 
in the current world, my world of science is still an exciting conversation 
in my mind that is ongoing. 
 
Find out more about Sreelaja’s research here  
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Various stages of cell division, Mitosis (Image credit: Sreelaja Nair) 
In India, Pancreatitis, which refers to inflammation of the pancreas, may 
primarily be acute and chronic, while autoimmune (a form of chronic 
pancreatitis) constitutes a very small proportion. Globally, the most 
common risk factors ascribed to acute pancreatitis are alcohol, smoking 
and gallstones. Acute pancreatitis is characterised by inflammation of the 
pancreas that could be associated with pancreatic injury (necrosis), 
systemic inflammatory response and multiorgan failure resulting in 
death. A substantial proportion of patients with pancreatic necrosis can 
develop infection of necrotic pancreas, especially from the second week 
of disease onwards. Fortunately, up to 75% patients with acute 
pancreatitis develop mild disease that resolves without the need for 
much intervention. However, there are no specific curative modalities for 
the remaining 25% who develop moderate to severe disease; and 
treatment is restricted predominantly to organ support and treatment of 
complications. The absence of specific treatment stems from a relative 
lack of understanding of the early pathogenesis of the disease in 
humans.  
 
Challenging the role of proteases in  pancreatic injury and inflammation 
 
Several elaborate mechanistic studies had been conducted previously in 
experimental models based on which treatment modalities such as the 
use of protease inhibitors (gabaxate, nafamostat) have been shown to be 
beneficial in experimental models, but results in clinical trials were 
heterogeneous. This led to an important question- is protease activation 
really required for acute pancreatitis? The concept of pancreatic intra-
acinar activation of trypsinogen to trypsin had been held as the central 
dogma in the pathogenesis of acute pancreatitis. We challenged this 
century old question couple of years back, and conducted experiments 
where we induced acute pancreatitis in wild-type and trypsin knock-out 
mice. We observed that there was pancreatic injury even in the absence 
of trypsin, and there was parallel activation of the inflammatory cytokine, 
NF-kB (Gastroenterology, 2011). These data clearly implied that the 
protease, trypsin, though important, is not mandatory for development of 
pancreatic injury and inflammation. 
 
In order to delve further into the role of trypsin in the pathogenesis, we 
conducted experiments in Prof Ashok Saluja’s lab, University of 
Minnesota, USA, where we could demonstrate a novel paradigm of 
pancreatic acinar cell apoptosis or necrosis. Our data clearly showed that 
it is the concentration of the hydrolytic enzyme, cathepsin B in the 
cytosol of the acinar cells that determines whether the acinar cell will 
undergo apoptosis or necrosis. An important early event that has been 
consistently shown to occur in acute pancreatitis is co-localization of 
lysosome and zymogen containing organelles, which now has been 
proven to be impaired autophagy. In our studies, we observed that the 
role of trypsin is to make the membranes of autophagic vacuole 
permeable, through which cathepsin B leaks out into the cytosol and 
lead to acinar cell apoptosis or necrosis (Gastroenterology 2016). 
However, these events occur very early (in a matter of minutes) in the 
pathogenesis of acute pancreatitis. In the clinical context, by the time a 
patient visits the hospital with severe abdominal pain, these events have 
already passed; and what the patient manifests is the result of the early 
events, i.e. a systemic inflammatory response. Therefore, in order to treat 
human pancreatic inflammation one needs to study human pancreatitis. 
This notion led our group to embark into experimental pancreatitis using 
human pancreatic tissue with bile acid and alcohol. Our studies revealed 
that autophagy occur in human biliary acute pancreatitis and the acinar 
cell is the earliest source of cytokine release. These cytokines then 
activate the peripheral blood mononuclear cells (PBMCs) that flow 
through the pancreatic circulation. The cytokines liberated by the 
activated PBMCs lead to a systemic inflammatory response syndrome 
and also cause a second wave of injury to the pancreatic acinar cells. We 
believe it is the second wave of cytokines (from the PMBCs) that 
determine the severity of the disease in patients (manuscript submitted 
and under revision). 
 
Identifying inflammatory biomarkers to predict infection of necrotic 
tissue in patients with acute pancreatitis 
 
As patients with acute pancreatitis go into the second week, a proportion 
with necrosis develops infection in the necrotic tissue. The question here 
is why only a proportion of patients with necrosis develop infection? In 
sepsis literature there is an entity called Compensatory Anti-
Inflammatory Response Syndrome (CARS), in which there is down 
regulation of important cell surface receptor, HLA-DR, involved in 
immune response, and up regulation of the anti-inflammatory cytokine 
IL-10, among other mediators. Earlier, studies had indicated that HLA-DR 
down regulation could be associated with infected pancreatic necrosis in 
humans. We tested this in patients with acute pancreatitis admitted 
within 72 hours of disease onset, where we divided patients with and 
without infected pancreatic necrosis and looked for IL-10 and HLA-DR 
expression during the first and second week of illness. We observed that 
irrespective of eventual development of infected pancreatic necrosis, the 
HLA-DR is down regulated in nearly 90% of patients during the first 
week. However, HLA-DR down regulation persisted till second week only 
in those patients who developed infected necrosis. The relative risk (95% 
CI) for developing infected necrosis in the patients who continued to 
have HLA DR down-regulation into the second week of the disease was 
2.8 (0.9-8.8). Along with this, IL-10 increased during second week only in 
the patients who developed infected necrosis (manuscript in 
preparation). These data show that dynamic changes in these markers 
could be potential biomarkers that could predict development of infected 
necrosis. This needs further validation though. Currently we are 
evaluating in an experimental setting and also in patients with acute 
pancreatitis who present early in the disease if gut microbial dysbiosis 
could increase the susceptibility to infections and severity of the disease. 
 
Diabetes in chronic pancreatitis is associated with infiltration of 
pancreatic islets with immune response regulating cells 
 
Recurrent acute pancreatitis, especially those related to alcohol intake 
and those that are idiopathic (most of these are associated with genetic 
polymorphisms), progress to chronic pancreatitis. It was earlier shown 
that 50% of alcohol-related recurrent acute pancreatitis develops 
features of chronic pancreatitis in two years.  We had recently shown that 
New insights into the underlying molecular 
mechanisms in acute and chronic Pancreatitis 
 
Dr Rupjyoti Talukdar, Intermediate Fellow 2011 
Asian Institute of Gastroenterology (AIG), Hyderabad 
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Synthesis of proteins is key for maintaining optimal status of a cell. The 
step involved in conversion of RNA to protein (translation) is highly 
regulated to control protein output in response to physiological status of 
cell. Our work identifies role of a posttranslational modification of RNA-
binding protein in regulating translation. Posttranslational modifications 
are chemical changes occurring on specific protein sequences. We have 
focused on arginine methylation, which is merely an addition of methyl 
group to arginine amino acid, of an RNA-binding protein Scd6 that acts 
as a negative effector of translation (translation repressor).  Scd6 has a 
three amino acid motif (Arginine-Glycine-Glyicine ; RGG) which has been 
shown to be involved in arginine methylation in other proteins 
containing this motif.  We have used baker’s yeast, Saccharomyces 
cerevisiae, as our model organism owing to a) the extreme ease of 
working with it and b) conservation of fundamental biological processes 
with humans.   
  
We observed that Scd6 gets arginine methylated and Hmt1 (the 
predominant methyltransferases in yeast) is required for its methylation. 
Characterization of the arginine methylation defective (AMD) mutant of 
Scd6 indicated that this modification is important for its repression 
activity. Specifically, the Scd6 AMD mutant fails to induce formation of 
RNA granules (markers of translation repression process).  Upon probing 
the molecular mechanism, we have learnt that methylated Scd6 is able 
to interact with Eukaryotic Translation Initiation Factor 4 Gamma 1 
(eIF4G1) better than unmethylated Scd6. It has been observed earlier 
that Scd6 represses translation by targeting eIF4G1. Whether 
methylation directly improves binding of Scd6 to eIF4G1 remains to be 
explored. 
  
This work helps us understand the contribution of arginine methylation 
to the fundamental process of messenger RNA fate determination. Since 
proteins with sequence and functional similarity (ortholog) to Scd6 are 
present in all higher organisms (including humans), we think that the 
finding reported by us might well be conserved in higher organisms. 
Further experiments will be required to test this idea. We are currently 
exploring if arginine methylation affects other translation repressors in a 
similar manner. Our long-term goal is to understand the mechanistic 
basis of mRNA movements in and out of translation.  
 
Arginine methylation promotes translation repression activity of eIF4G-
binding protein, Scd6. Gopalakrishna Poornima  Shanaya Shah  
Venkadasubramanian Vignesh  Roy Parker Purusharth I. Rajyaguru. 
Nucleic Acids Res (2016)  
Elucidating the effect of RNA-binding 
protein modification on gene 
regulation in a baker’s yeast model  
 
Dr Purusharth Rajyaguru, Intermediate Fellow 2012 
Indian Institute of Science, Bangalore 
recurrent acute pancreatitis in the presence of Claudin2 rs7057398 CC 
genotype was associated with seven fold higher risk of progressing  
to chronic pancreatitis (Journal of Gastroenterology and Hepatology, 
2015). The pathological hallmark of chronic pancreatitis is pancreatic 
fibrosis, while clinically it is characterized by recurrent intractable pain, 
malnutrition resulting from Pancreatic Exocrine Insufficiency (PEI), and 
Type 3c diabetes that is distinct from Type 1 and 2 diabetes. In India, 
chronic pancreatitis and the related manifestations, including diabetes, 
mostly occur early in life, and we have recently shown that diabetes in 
chronic pancreatitis is associated with infiltration of immune response 
regulating cells (Th1 and Th17) into the pancreatic islets that is 
associated with secretion of the cytokine, interferon- (Pancreas 2016).  
 
Alteration of gut microbiota in chronic pancreatitis 
 
Since there is fat maldigestion due to PEI in chronic pancreatitis, it is 
likely that there will be an alteration in the gut microbiota. We tested for 
this by metagenomic 16S rDNA V3-V4 region sequencing and observed 
that there was a significant reduction in the relative abundance of the 
species Fecalibacterium prausnitzii in patients with chronic pancreatitis 
who had diabetes compared to those who did not. This bacterium is 
known to maintain the gut barrier integrity, implying that its reduction 
could result in disrupted gut barrier. We also observed an increase in LPS 
synthetic pathways among the intestinal bacteria and a parallel increase 
in plasma endotoxin. This correlated positively with blood glucose and 
negatively with relative abundance of Fecalibacterium prasunitzii. Taken 
together, these findings led to the hypothesis that pancreatic exocrine 
insufficiency and fat malabsorption results in gut microbial imbalance 
(dysbiosis) in chronic pancreatitis, which results in gut barrier alteration 
and translocation of endotoxin into the circulation. The circulating 
endotoxin could then contribute to islet dysfunction, along with other 
possible mechanisms. It is known from earlier experimental studies that 
endotoxins could result in islet injury via TLR4. We also observed 
correlation of the relative abundance with several bacteria genera with 
nutritional parameters (Scientific Reports, 2017). The current attempt in 
the lab has been to elucidate the mechanistic insights of the above 
findings that would provide better understanding of the connection 
between pancreatitis and gut microbiome.  
Arginine methylation of Scd6 by Hmt1 augments its repression activity by 
promoting its interaction with eIF4G1. 
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Why does rabies still plague India  
in the 21st century? 
 
By Dr Abi Tamim Vanak 
Intermediate Fellow 
Ashoka Trust for Research in Ecology and the Environment, Bangalore 
 
In a rapidly changing world, responsive and scientifically sound 
surveillance systems are needed in order to better understand, and 
possibly predict outbreaks and spread of zoonotic infectious diseases. 
Unfortunately in India, most efforts towards strengthening response to 
zoonoses have mainly focused on improving technical and laboratory 
capacity. Surveillance and the collection of field data have either been 
neglected or at best patchily implemented. 
  
Making a case for rabies control in India 
  
The case of rabies in India is a classic example of such neglect. Despite 
India having more cases of human rabies deaths (20,000) than any other 
country in the world, we suffer from a massive knowledge deficit. Even 
today, the primary citation for rabies incidences in India comes from one 
study carried out in 2003. One of the key reasons for this grim reality is 
the lack of a comprehensive policy for rabies control that is based on 
rigorous scientific study of disease dynamics in India. 
  
The present strategy for the control of rabies in India is based largely on 
the World Health Organisation’s guidelines, which prescribe annually 
vaccinating 70% of the dog population to reduce the prevalence of 
rabies in the dog population. Mass vaccination is supposed to be 
accompanied by vector population reduction in the form of Animal Birth 
Control (ABC) programs . However, these strategies have rarely been 
systematically implemented in India, and their efficacy or practicability 
rarely tested under Indian conditions. 
  
Unlike other countries in Africa and Asia, India has a panmictic free-
ranging dog population that occurs at high densities. There is also a 
high turnover rate in the dog population due to high reproduction and 
low adult survival. A typical street dog is estimated to live no more than 
3 years. Furthermore, even though a high proportion of free-roaming 
dogs are quasi-owned, i.e. they may be associated with a reference 
person and occasionally fed, they are not restrained or provided with 
health and fertility control interventions. However, frequent vaccination 
campaigns are necessary to eradicate canine rabies, since a single rabies 
vaccine injection does not result in long lasting neutralizing antibodies. 
If vaccination coverage is not sustained, rabies can rapidly re-establish 
number.  
  
Not surprisingly, this target 70% vaccination coverage has rarely been 
achieved by any program in India (with one or two notable exceptions). 
Despite this, many cities attribute a reduction in the incidence of human 
rabies cases to the success of dog mass vaccination programs.  
 
It is more likely that better education levels in urban centres, as well as 
increased accessibility to Post-exposure Prophylaxis (PEP), explain the 
decrease of symptomatic rabies in humans in some areas. Given that 
rabies is not a reportable disease, and because symptoms can vary, 
rabies in dogs can persist in urban India despite claims to the contrary. 
Circumstances in rural areas are much poorer. There are very few 
targeted campaigns for education or vaccination in villages and almost 
no sero-epidemiological evaluation of vaccination efficacy, even though 
the majority of rabies cases are reported from villages. 
  
A conservative estimate puts the human death toll from rabies in India 
at ~20,000/annum, the economic cost of PEP following dog bites at ~INR 
200 crores/annum with loss of 38 million man-hours for post-exposure 
treatment. The cost of rabies prevention measures in towns and cities is 
not known, but is likely to run in the hundreds of crores/annum. Thus, 
both human as well as economic cost of rabies is not insignificant. Given 
that rabies is a wholly preventable disease, these statistics provide an 
example of a failure of the scientific as well as policy environment 
around rabies control.  
  
In these unique circumstances, it is important to understand the 
dynamics of rabies in these super-abundant free-ranging dog 
populations, so that a site-specific rabies control protocol may be 
devised. It is also important to understand that rabies is unlikely to ever 
be eradicated in an Indian context, because of attitudes of people to 
free-ranging dogs, unwarranted beliefs about vaccinating dogs, 
dependence on traditional health systems as well as possible alternative 
hosts in wildlife populations. 
  
Despite the recognition that dogs are the primary vectors of rabies in 
India, there have been few studies to understand the population ecology 
of dogs and how this may impact rabies spread or its control. India has 
the highest proportion of un-owned, free-ranging dogs in the world. 
Because of poor health care of these dogs, population turnover rates are 
usually very high. Furthermore, free-ranging dogs belong to different 
categories (e.g. village dogs, farm dogs, herding dogs, feral dogs), with 
markedly different ecology and behavior. In such circumstances, 
maintaining herd immunity using a blanket strategy of mass vaccination 
campaigns impracticable. Our current project funded by the Wellcome 
Trust/DBT India Alliance aims to use a “One Health” approach by 
integrating the fields of animal ecology, epidemiology and movement 
ecology to understanding rabies dynamics in India across the human-
domestic dog-wildlife spectrum. 
  
Counting dogs 
  
We use a combination of basic and high-tech ecological techniques to 
determine population size, demography, movement patterns and 
foraging ecology of free-ranging dogs. This starts with population 
  
  
Image credits : Abi Tamim Vanak 
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 surveys using a technique called mark-resight, where in a city or rural 
area is divided into grids, and systematically surveyed for dogs. Each dog 
is photographed and its location recorded using a GPS and a 
smartphone app. Each survey is repeated three times to obtain a 
“capture” history for each dog. This enables the use of sophisticated 
Capture-recapture models of population estimation to determine 
population size and density in a given area. We also record the presence 
of possible food sources, so that a resource explicit map of dog density 
can be created.  
  
For a subset of study areas, we capture and fit uniquely numbered 
collars on a cohort of dogs to enable identification during resampling 
surveys every 3 months. This allows us to determine survival and 
population turnover rates in dogs across an urban rural gradient.  
  
Assessing vaccination as a means to reduce the burden of rabies 
  
Mass vaccination of dogs is prescribed as the best option of rabies 
elimination, with the assumption that vaccinating 70% of the dog 
population confers population-wide immunity against rabies. However, 
this assumption has not been epidemiologically tested in India. Given 
the high turnover rates in free-ranging dog populations in the 
developing world, and the possible presence of non-responders and 
immunologically challenged individuals, it is likely that this assumption 
is violated. For example, in a study conducted in Chandigarh (Singh et al. 
2011), the authors found that only 16% of owned-dogs had protective 
antibody titers for rabies, whereas only 1% of free-ranging dogs tested 
had the necessary antibody titers. 
  
This shows that, not only are continuous and sustained mass vaccination 
campaigns required, but also surveillance and testing for population 
level protective antibody titers is required. Furthermore, dog populations 
are not homogeneous and consist of several categories (e.g. farm dogs, 
village dogs) with markedly different behavior and ecology. Accessibility 
of dogs for vaccination will also vary between these categories and 
regions, and so too the efforts necessary to achieve target vaccination 
coverage. For example, the logistics of vaccinating a high density dog 
population in an urban environment, consisting mostly of unrestricted 
and semi-restricted neighborhood dogs, would differ from that of 
vaccinating a low density, rural dog population, consisting of 
unrestricted family and village dogs. Because of these challenges, there 
is an unknown proportion of dogs that is always without vaccination 
coverage, and in areas with a high dog population, this is enough to 
maintain enzootic status. To test for the efficacy of vaccination as means 
to reduce rabies incidence, we are conducting a systematic longitudinal 
epidemiological survey across our study sites. We obtain a blood sample 
for every dog that is captured, and will test them for levels of 
neutralizing rabies antibodies at both the individual and population 
levels. In some cases, we also come across dogs that show rabies-like 
clinical symptoms. We test these dogs using a rapid field antigen kit 
(lateral flow device), to determine if they are actively shedding the rabies 
virus. For dogs that have died, we also obtain brain tissue samples for 
laboratory confirmation of rabies. 
  
Rabies dynamics in a multi-host system 
  
The vast majority of India’s free-ranging dogs live in rural areas, where 
they interact with wild carnivores. A potential exists for spill-over of 
rabies from the abundant reservoir host (dogs) to wolves (Canis lupus 
pallipes), jackals (C. aureus) and foxes (Vulpes spp.) as these species occur 
in close vicinity of human dominated areas throughout India. Even 
though it has been established that dogs are main reservoir for rabies in 
India, the dynamics of rabies transmission within and between these 
host populations continues to remain enigmatic. This is mainly due to a 
lack of disease ecology research on wild and domestic host species in 
India. To better understand the potential for spread of rabies from dogs 
to wildlife and back, we are using a movement ecology approach to 
determine interaction rates. We capture and fit with GPS telemetry 
devices, dogs, jackals and Indian foxes in the same area. These GPS 
collars provide a high temporal resolution of data, allowing us to 
determine the movements of each of these species, the overlap in their 
home-ranges, and the potential for direct or indirect contact. 
  
The final step of this project will be to bring together all these empirical 
data to parameterise agent-based models to understand the dynamics of 
rabies in these multi-host systems. We expect that various components 
of the model will allow us to determine pathways for rabies spill-
over/spill-back, link populations, and effectiveness of control measures. 
Ultimately, we may be able to use these model simulations to test 
possible alternate strategies to control rabies such as identifying areas 
of high rabies endemicity, and probable pathways of transmission, and 
target vaccination and population control measures. 
  
Ultimately, controlling this dreaded disease may well depend on 
changing our behavior and attitudes to the presence of free-ranging 
dogs. Dogs are companion animals, and their welfare is best served 
under human care. If we are to eliminate canine rabies in India, humans 
need to take full responsibility for dogs by strengthening the laws that 
govern pet ownership, limit the population of free-ranging dogs and 
ensure that dogs have adequate healthcare. This will result in win-win 
solutions for humans and for dogs. 
 
Why does rabies still plague India in the 21st century? 
Image credits : Abi Tamim Vanak 
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In conversation with 
Prof Mohan Balasubramanian 
Warwick Medical School 
University of Warwick, Coventry, UK 
What motivated you to become a scientist? 
 
I was born in a very conventional household, with the usual expectations 
from my parents- study and get a job. There was no pressure from my 
family as such to choose a particular career, however, it was clear that 
one had to do well in whatever they chose to pursue.  My motivation for 
science came late, when I was doing undergraduation in chemistry.  I 
went to MSU Baroda to do my Masters in Microbiology and 
Biotechnology where I had the good fortune to meet a fantastic and 
passionate teacher Prof Bharat Chattoo, who was also an outstanding 
scientist. Just being around him made us high and excited for science. 
Even though we were Masters students he made us think like PhD 
students and Postdocs. There weren’t a lot of research facilities for us in 
the late 80s in Baroda but he helped us develop the intellectual process 
of doing science – coming up with a hypothesis, testing it, designing 
experiments and so on.  Prof Chattoo was singularly responsible for my 
choosing science.  
 
and if you were not a scientist, you would be.. 
 
It is hard to say. I did have a lot of interest in cricket. In fact, I got 
admission in MSU Baroda because of that, but I never wanted to make 
my career in that field.  Music is a secret passion too, but I cannot say if I 
would have become a performing artist either. It really could have been 
anything, but what I know for certain is that whatever career I would 
have chosen I would have committed to it completely.   
 
Could you briefly take us through your scientific journey and about your 
interest in biology.  
 
I wasn’t interested in Biology to start with; it was mostly Chemistry. 
However, meeting Prof Bharat Chattoo changed that for me and I slowly 
moved from chemistry to molecular biology, then genetics and cell 
biology, a path he showed us.  During my Masters in Baroda, Prof Chattoo 
used to get hard copies of Cell, Nature and Science magazines a week 
after they would get published, which helped us keep abreast with 
current scientific knowledge.  
 
From Baroda I went to a small town in Canada, Saskatchewan to do my 
PhD with a leading plant biologist, Dr Sean Hemmingsen. The turning 
point in my PhD came when my supervisor went to Oxford to visit Paul 
Nurse who had cloned and characterized important cell cycle proteins in 
budding yeast. Interestingly, these breakthrough research findings were 
published during Sean’s sabbatical there.  Sean brought back these cell 
cycle mutant protein collection that Paul had isolated, to our lab. I read 
up more on the cell cycle literature and got hooked to the field of cell 
cycle regulation, which was not well-studied at that time.  I found the 
topic of cytokinesis very interesting, as it combines cell cycle control with 
a beautiful mechanical problem of cell division. I continued my this 
research on cytokinesis in yeast when I moved to Prof Kathy Gould’s lab 
in Vanderbilt University, Nashville for my postdoc. I have been intrigued 
by the mechanical question of how the cell division apparatus assembles 
and contracts and how much force is needed to divide the cell. This led 
me to make a departure from genetics and imaging and I teamed up 
with a group in Japan and biochemically purify and characterise the cell 
division apparatus and employed single molecule motility assays to 
enhance our understanding of this complex machinery at a molecular 
level. The research problem I chose almost 30 years ago is still throwing 
up more and more interesting questions, which keeps us going in the lab.   
 
What according to you are the challenges in your field of research and 
how do you see the field evolve in the next ten years? 
 
The descriptive work in this field is over. The challenge now is to get 
quantitative understanding of various cytokinesis phenomena. We are 
looking at a cellular machine which is very complex, perhaps even more 
than the ribosome. CryoEM is revolutionary technique and I am sure it 
will have major impact on the field. Cytokinesis is a huge structural 
biology problem to crack, big problem in quantitative cell biology and in 
soft matter physics. We have to bring these together to improve our 
understanding of this complex cell division apparatus.  
 
Any other field that has caught your interest and attention? 
 
I have become very interested in synthetic biology approaches to 
assembling designer proteins and to reconstruct signaling pathways 
involved in cell division. The logic for doing this is very simple; if we can 
reconstitute a functional cell pathway, it would mean our understanding 
of it is correct.  So we are trying to understand key steps in 
developmental biology, which is not our field,  but I am very interested in 
employing our technology to reconstruct complex signaling networks to 
understand how early development occurs.  
  
Any advice for young researchers and students? 
 
The  one advice of my PhD mentor that has stayed with me is that, 
communication is as important as the experiment. It is important to be 
able to effectively communicate both verbally and in writing what you 
are trying to do. In addition to this, my other advice to biomedical 
scientists today would be to appreciate that every biological problem has 
a physical and chemical basis and therefore not restrict themselves to 
only descriptive work. It is important to reach out to other disciplines to 
broaden your research horizon. I highly recommend that researchers take 
teaching very seriously along with the research work. If you teach 
regularly you will see tangible difference in the way you envision and do 
your science.   
 
Find out more about Mohan’s research here 
13. 
Prof Mohan Balasubramanian is the Pro-Dean, Biomedical Research at Warwick Medical School, Coventry, UK. His areas of research 
include cell cycle control, cytokinesis, mitosis, morphogenesis, cell physiology, yeast genetics. He is currently a member of the 
Wellcome Trust/DBT India Alliance Senior and Intermediate Fellowship selection committee. In this interview he shares his 
scientific beginnings and current research interests. 
About India I EMBO Symposia 
 
The Wellcome Trust/DBT India Alliance  and European Molecular Biology 
Organization (EMBO) will jointly fund up to three meetings per year in 
India. The meetings should address discovery and innovation through an 
interdisciplinary approach, with the speakers and participants discussing 
important global challenges in the context of the life sciences. 
  
The meetings should be small, with 10 – 15 highly acclaimed 
international speakers and 50 – 75 participants, allowing early to mid 
career scientists to interact with leading international experts during a 
period of three days. 
  
Proceedings from the meeting should be drafted as a position paper to 
advise the India Alliance regarding this area of research. The paper 
should in particular outline if and how research covered by the meeting 
could be beneficial to India. India Alliance may consider increasing 
funding for research in that area following expert advice and review. 
 
Benefits 
 
• The maximum funding available for an India | EMBO Symposia is 
60,000 euros. 
 
• EMBO also supports the organizers and meeting in the following 
ways: 
 
• EMBO creates a dedicated meeting webpage, including registration 
and abstract submission forms. 
 
• EMBO provides a poster and advertising in selected print and social 
media channels.  
 
• Organizers can apply for funds for an EMBO Young Investigator 
lecture, EMBO Science Policy lecture and EMBO Women in Science 
lecture. 
 
 
Eligibility  
 
• India | EMBO Symposia must take place in India, but scientists from 
anywhere in the world are eligible to apply, independent of their 
nationality. 
 
• India | EMBO Symposia must cover frontier, pioneering and 
interdisciplinary areas of life sciences that are underserved in India, 
and include speakers with interdisciplinary expertise. Furthermore, the 
application should include a list of (mostly) confirmed speakers.  
 
• For detailed information on the eligibility criteria, including the format 
of the meeting, please consult the application guidelines (pdf).  
 
 
 
 
 
 
Application process 
 
• Applications for India | EMBO Symposia will be accepted twice in 2017 
and must be submitted through the online system. Organizers should 
apply at least 6-12 months before the proposed date of the meeting. 
The deadline for second round is 15 July 2017, 14:00 CEST which is 
will be tentatively launched on 15 April 2017.  
 
• Applicants will be asked to complete an online and an offline 
application form. 
 
• All incoming applications are screened to ensure eligibility 
requirements are met. 
 
• The decision on which proposals receive funding is jointly made by 
the EMBO Course Committee and the India Alliance Meetings 
Committee in May and October.  
 
• All applicants are informed of the outcome of their application by 
email shortly after the committee meetings. 
 
Required documentation 
 
Applicants will be asked to provide: 
• A list of organizers  
• Proposed title and topic of the meeting 
• Reasons for holding a meeting on the proposed topic 
• Information on any competing or similar meetings held in the current, 
proposed or following year 
• Proposed date and location 
• List of proposed speakers/instructors 
• Draft programme 
• Participant selection criteria and number of participants 
• Proposal for the position paper  
• Information on the practical component of the meeting (if applicable) 
• Draft budget 
 
Selection process 
 
The selection process involves the following steps: 
• All incoming applications are screened to ensure eligibility 
requirements are met. 
 
• The decision on which proposals receive funding is jointly made by 
the EMBO Course Committee and the India Alliance Meetings 
Committee in May and October.  
 
• All applicants are informed of the outcome of their application by 
email shortly after the committee meetings. 
 
For detailed information on the application process, key dates, format of 
the meeting and required documentation, please consult the application 
guidelines or visit India | EMBO Symposia website.   
 
For any enquiries, please write to workshops@wellcomedbt.org 
  
 
INDIA ALLIANCE 
Event support 
Note: Second round will be launched tentatively on 15 April 2017.  
Applications submitted in the first round announced on 15 December 2016, are currently under review.  
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We recently concluded our 15th two-day Science Communication 
(SciComm) Workshop in Hyderabad, which was attended by 32 
participants mostly comprising of PhDs, Postdocs, young faculty and 
clinicians from 26 different institutions across India. Over the two days, 
participants received training on research ethics, manuscript and grants 
writing and presentation skills. In addition to these, there were engaging 
discussions on career choices in academia and the importance of 
mentorship towards building a successful career. Our eminent panel of 
mentors included, Dr Sandhya Koushika (TIFR  Mumbai), Dr Sunil Laxman 
(InStem, Bangalore; IA Intermediate Fellow), Prof Amitabha 
Chattopadhyay  (CCMB, Hyderabad), Dr Mahesh Kate (CMC Ludhiana; IA 
Intermediate Fellow), Dr Rupinder Kaur (CDFD, Hyderabad; IA Senior 
Fellow) and Ms Sumathy Haridas (HR consultant, Bangalore).  The two 
days entailed enthusiastic interaction between the participants, mentors 
and India Alliance staff about the workshop modules, career choices and 
their current research. The eagerness to learn and active questioning at 
the workshop by the participants reinforced the importance of Science 
Communication in nurturing and training the future researchers of India.  
 
The next two-day Science Communication workshop will be held tentatively 
in September 2017. Announcement for the same will be made on our website 
shortly. 
For more details on our Science Communication workshops, visit our website  
19th SciComm101 workshop 
13 February 2017,  Manipal University 
On 13 February 2017, India Alliance’s SciComm101 team reached the 
vibrant campus of Manipal University.  This 19th SciComm101 Workshop 
was attended by around 100 participants, mostly senior PhD students, 
clinical and public health researchers and junior postdocs from different 
departments and campuses in Manipal University.  The Workshop 
attempted to highlight the ethical considerations in biomedical research, 
importance of good presentation skills for a successful academic career 
and useful tips on manuscript and grant writing through a combination 
of lectures and case study discussions.  
 
Read a short coverage of this Workshop in The Hindu. 
 
To request one at your institution, send your request to 
workshops@wellcomedbt.org 
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15th Two-day SciComm workshop 
2-3 March 2017,  Hyderabad 
Snapshots from the 15th two-day SciComm Workshop in Hyderabad 
15. 
The Wellcome Trust/DBT India Alliance in partnership with Nature India and National Institute of Immunology, New Delhi is to 
announce  "Visualising Science", a first-of-its-kind Workshop in India, which aims to introduce scientists to visual tools and 
methods  that make science communication more effective and interesting.  
 
What the two-day event would include: 
* A science photography workshop & hands-on training 
* Sessions on infographics, illustrations, documentary film making & virtual reality 
* Photo Exhibition of top ten entries from the Nature India Photo Contest 
 
Where: National Institute of Immunology, New Delhi 
When: 30 & 31 March 2017  
 
REGISTRATION FOR THIS EVENT IS NOW CLOSED 
 
For inquiries, write to public.engagement@wellcomedbt.org 
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17. 
INDIA ALLIANCE  
PUBLIC ENGAGEMENT 
INDIA ALLIANCE  
PUBLIC ENGAGEMENT 
“Public or community engagement most simply 
can be defined as a symbiotic relationship and 
exchanges between the public and 
research/scientific community. Public engagement 
must result in a meaningful impact on both the 
groups and should not be restricted to 
dissemination of research knowledge or its 
uptake.” Survey respondent 
 
The Wellcome Trust International Engagement 
gathered views on Public and Community 
Engagement with research in India and Africa. 
The report prepared by them includes 
perceptions, challenges and training needs for 
public engagement as shared by researchers 
and public engagement specialists. “The survey 
results highlighted 5 key areas that could help 
improve support for public engagement in 
their region: increased availability of funding, 
dedicated staff, senior management support, 
training and organisational structures”. Read 
their full report here.  
18. 
“What do you think is the main benefit, if any, of researchers engaging with the public?” 
 
Interest and commitment to public engagement 
“What would you say is the main challenge associated with researchers engaging with the public 
or local communities?” 
“The majority of respondents thought that 
learning from public groups and ensuring that 
research was relevant to the public was the main 
benefit of engagement.” 
“After competing pressures on their time, 
insufficient specialist staff at their institution, a 
negative perception and lack of recognition of 
public engagement, almost half (47%) of 
international respondents highlighted not enough 
funding or difficulties getting funding as a main 
barrier to public engagement.” 
“The survey indicated a keen interest and 
commitment to public engagement, with 83% 
saying that they would like to spend more time 
engaging with the public. However only 19% of 
respondents felt very well equipped to engage 
with the public about their research. 34% of 
respondents had not received or been offered 
public engagement training in the past 5 years. “ 
Please send your feedback, suggestions and contributions to 
public.engagement@wellcomedbt.org 
Follow us on  
www.wellcomedbt.org 
Other announcements 
This scheme is aimed at encouraging young, talented, enthusiastic and result-oriented scholars to take up industry-relevant research. Under this scheme, the full-time PhD 
scholars get double the money that they would otherwise get for doing research. Maximum government fellowship in India at any academic or research institute is 
approximately Rs 36,400 per month, including House Rent Allowance (HRA) for SRF category. Under the Prime Minister’s Fellowship Scheme for Doctoral Research, the 
scholars get double the JRF/SRF as scholarship (as per applicable slabs). While one-half of this scholarship comes from the government, the second half comes from a 
partner company which also works closely with the candidate on the research project. The first batch commenced in 2013. The scheme has been made open-ended since 
September 2014, allowing aspirants to apply anytime within 14 months from their PhD registration. Visit the website to find out more about this funding opportunity.  
19. 
Postdoctoral fellow in a research project funded by a Wellcome Trust/DBT India Alliance Intermediate Fellowship Grant 
  
Title: Molecular mechanism of Cell-cell adhesion by non-classical cadherins 
This project aims to decipher the molecular mechanism of non-classical cadherins in cell-cell junction. Recently, non-classical Cadherin, cadherin-23 has been found at the 
cell-cell junction of Breast-cancer cells mediating both homotypic and heterotypic cell-adhesion with Fibroblasts. We are interested to understand the molecular and 
structural details of these molecules at the cell-cell junction.  
We are an interdisciplinary research group who use single molecule techniques to understand biology quantitatively. To know more about our research interests, please visit 
our web-page. 
Positions: One 
Duration: One year and extendable up to 3 years upon evaluation 
Emoluments: As per IISER Mohali 
Essential Qualifications:  
The applicants should hold a PhD or MD/PhD, and have a strong training in molecular biology and cell biology. Expertise in fluorescence based and AFM based imaging 
techniques and bioinformatics are desired. It is also essential that the candidates have strong first author publication history. Interested applicants should email their CV 
and a 1-page cover letter (describing their past accomplishments, research interests and career goals) along with names and contact information of three references 
to: srakshit@iisermohali.ac.in. 
 
Submission Deadline for Full Application: 30th April, 2017 
Interview (walk-in or skype): 15th May-17th May, 2017 
Exact date, time and venue will be intimated to the shortlisted candidates by email. 
Joining Date: 1st June, 2017 
 
Contact person: 
Sabyasachi Rakshit, PhD 
Assistant Professor 
Wellcome Trust/ DBT Intermediate Fellow 
Centre for Protein Science, Design and Engineering 
Department of Chemical Sciences 
Indian Institute of Science Education and Research Mohali, Sector 81, SAS Nagar, Manauli, Punjab 140306 
India 
Web: https://sites.google.com/site/rakshitslab/home 
  
